Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
- Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- Pharmacological and Behavioral Treatment After Bariatric Surgery
- Use of Mysimba in Patients With Weight Regain After Bariatric Surgery
- Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
- Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
- Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.
- A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery
- Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
- Relapse Prevention in Stimulant Use Disorder
- Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
- Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
- Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
- Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients
- Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder
- Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
- Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
- An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
- Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants
- Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia
- Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants
- Naltrexone/Bupropion Cardiovascular Outcomes Study
- Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery
- Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
- Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
- Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
- Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
- A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
- Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
- Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study
- A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects
- A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
- A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent
- A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
- Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
- A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
- Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
- Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
- Abilify Therapy for Reducing Comorbid Substance Abuse
- Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
Clinical trials list
click for details